Rhonda Fleming v. United States of America, et al.

District Court, N.D. California·Decided March 20, 2026·No. 3:22-cv-05082·Unknown

Opinion

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA

RHONDA FLEMING, Case No. 22-cv-05082-RFL

Plaintiff, ORDER GRANTING USA’S MOTION v. TO DISMISS AND DENYING WARDEN JUSINO’S MOTION TO UNITED STATES OF AMERICA, et al., DISMISS Defendants. Re: Dkt. Nos. 162, 163

Plaintiff Rhonda Fleming brings suit against Defendants United States of America, William Lothrop (in his official capacity as Acting Director of the Federal Bureau of Prisons (“BOP”)), and Thahesha Jusino, former warden of Federal Correctional Institution, Dublin (“FCI Dublin”). In her operative complaint, Fleming alleges that while she was incarcerated at FCI Dublin, she was subjected to toxic environmental conditions and denied access to necessary medical treatment for her worsening health. (Dkt. No. 133-2 (“TAC”).) Fleming asserts claims under the Federal Tort Claims Act (“FTCA”) for negligence and intentional infliction of emotional distress and an Eighth Amendment claim for injunctive relief against the United States and Lothrop, and an Eighth Amendment Bivens claim for damages against Jusino. (TAC ¶¶ 71– 116.) Defendants move to dismiss the complaint for failure to state a claim under Federal Rule of Civil Procedure 12(b)(6). (Dkt. No. 162 (Jusino); Dkt. No. 163 (United States and Lothrop).) For the reasons that follow, the United States and Lothrop’s motion is GRANTED, and those claims are dismissed without prejudice to being refiled after presenting them to the Bureau of Prisons for its evaluation. Jusino’s motion is DENIED. I. BACKGROUND The facts detailed below are based on the allegations contained in the operative complaint, the truth of which the Court accepts for purposes of resolving the motions to dismiss. See Boquist v. Courtney, 32 F.4th 764, 772 (9th Cir. 2022). A. Conditions at FCI Dublin FCI Dublin was a federal low-security women’s prison in Dublin, California. (TAC ¶ 11.) Although poor living conditions are alleged to have been “serious, systemic problems . . . at FCI Dublin . . . for decades,” whistleblowers and media reports revealing the egregiousness of the living conditions have caused the prison to come under “intense public scrutiny” in recent years. (Id. at ¶¶ 14–15.) Prisoners at FCI Dublin were exposed to mold, asbestos, and walkways covered in wild geese excrement, all of which can cause severe negative health effects including mesothelioma, upper respiratory tract symptoms, and histoplasmosis. (Id. at ¶¶ 16–17.) After officials of the prison workers’ union filed whistleblower complaints in 2022, the U.S. Office of Special Counsel determined that FCI Dublin had violated Occupational Safety and Health Administration standards by exposing prison staff and inmates to asbestos. (Id. at ¶ 18.) Despite all this, however, FCI Dublin “failed to remediate the toxic environmental conditions at the prison.” (Id.) Indeed, in March 2024, a Special Master was appointed to supervise FCI Dublin following a finding by another judge in this District that BOP had “proceeded sluggishly” in ameliorating the environmental conditions in FCI Dublin. (Cal. Coalition for Women Prisoners v. United States, No 23-cv-04155-YGR, Dkt. No. 222 at 1.)1 On April 15, 2024, BOP officials announced that they would close FCI Dublin. (TAC ¶ 21.) Individuals then incarcerated at FCI Dublin were transferred to “various other federal prisons throughout the country.” (Id.) B. Fleming’s Incarceration at FCI Dublin Fleming had originally been transferred from FCI Tallahassee to FCI Dublin on June 22, 2022, allegedly in retaliation for her asking for a prison grievance form. (Id. at ¶¶ 23, 45.) Upon

Free access — add to your briefcase to read the full text and ask questions with AI

Rhonda Fleming v. United States of America, et al., (N.D. Cal. 2026).

Rhonda Fleming v. United States of America, et al. (Rhonda Fleming v. United States of America, et al.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Estelle v. Gamble
429 U.S. 97 (Supreme Court, 1976)
Davis v. Passman
442 U.S. 228 (Supreme Court, 1979)
Carlson v. Green
446 U.S. 14 (Supreme Court, 1980)
Harlow v. Fitzgerald
457 U.S. 800 (Supreme Court, 1982)
McNeil v. United States
508 U.S. 106 (Supreme Court, 1993)
Department of the Army v. Blue Fox, Inc.
525 U.S. 255 (Supreme Court, 1999)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
John C. McGuckin v. Dr. Smith John C. Medlen, Dr.
974 F.2d 1050 (Ninth Circuit, 1992)
Clarissa Brady,plaintiff-Appellant v. United States
211 F.3d 499 (Ninth Circuit, 2000)
Brown v. Croak
312 F.3d 109 (Third Circuit, 2002)
Harris v. County of Orange
682 F.3d 1126 (Ninth Circuit, 2012)
Cion Peralta v. T. Dillard
744 F.3d 1076 (Ninth Circuit, 2014)
Juan Albino v. Lee Baca
747 F.3d 1162 (Ninth Circuit, 2014)
Dennis Walker v. Beard
789 F.3d 1125 (Ninth Circuit, 2015)
Ziglar v. Abbasi
582 U.S. 120 (Supreme Court, 2017)
Karim Khoja v. Orexigen Therapeutics, Inc.
899 F.3d 988 (Ninth Circuit, 2018)